Form 4 for SHW Sherwin-Williams
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-25 · accession 0000089800-24-000166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-27 | 2024-11-25 | SHW | CRONIN JANE M. | SVP - Enterprise Fin | M - OptEx | $147.49 | +5,499 | 17.2K | +47% | +$811.0K |
| D | 2024-11-27 | 2024-11-25 | SHW | CRONIN JANE M. | SVP - Enterprise Fin | G - Gift | $0.00 | -543 | 16.4K | -3% | $0 |
| D | 2024-11-27 | 2024-11-25 | SHW | CRONIN JANE M. | SVP - Enterprise Fin | S - Sale+OE | $398.06 | -5,161 | 16.8K | -23% | -$2.05M |
| D | 2024-11-27 | 2024-11-25 | SHW | CRONIN JANE M. | SVP - Enterprise Fin | F - Tax | $397.93 | -251 | 16.9K | -1% | -$99.9K |
| DM | 2024-11-27 | 2024-11-25 | SHW | CRONIN JANE M. | SVP - Enterprise Fin | M - OptEx | $0.00 | -5,499 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-25 | M | A | 3,700 | $136.85 | 21,977 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-25 | M | A | 1,461 | $140.10 | 18,277 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-25 | G | D | 543 | $0.00 | 16,360 | D | — | — | (F2) Represents a gift made by the Reporting Person to a charitable donor advised fund. |
| 4 | Common | Common Stock | 2024-11-25 | S | D | 5,161 | $398.06 | 16,816 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $397.91 to $398.39 per share. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2024-11-25 | F | D | 251 | $397.93 | 16,903 | D | — | — | |
| 6 | Common | Common Stock | 2024-11-25 | M | A | 338 | $295.83 | 17,154 | D | — | — | |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-25 | M | D | 3,700 | $0.00 | 0 | D | $136.85 · — to 2028-10-16 | 3,700 Common Stock | (F5) These options were granted on October 17, 2018 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-25 | M | D | 338 | $0.00 | 2,562 | D | $295.83 · — to 2031-10-17 | 338 Common Stock | (F6) These options were granted on October 18, 2021 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-25 | M | D | 1,461 | $0.00 | 0 | D | $140.10 · — to 2028-07-16 | 1,461 Common Stock | (F4) These options were granted on July 17, 2018 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. |